Skip to main content
. 2001 Nov;8(6):1196–1203. doi: 10.1128/CDLI.8.6.1196-1203.2001

FIG. 5.

FIG. 5

Correlation of uPAR expression with clinical activity. MLFI (MFI; ⊡) and percent (⧫) uPAR+ monocytes increased prior to a clinically documented exacerbation in placebo-treated (A) and glatiramer acetate (COP-1)-treated (B) patients. Arrows point to the onset of exacerbation. Data for representative patients were chosen for presentation.